NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
NU SKIN ENTERPRISES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.97−0.17 (-3.31%)
Close on Oct 19, 2026
- Market cap
- $241.52M
- P/E (TTM)
- –
- Dividend yield
- –
NU SKIN ENTERPRISES, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $258.55M | $271.74M | $282.98M | $291.35M | $304.55M | $316.54M | $322.52M | $334.91M | $349.39M | $372.10M | $398.22M | $429.39M | 18.8% | -15.1% |
| Southeast Asia/Pacific [Member] | $195.53M | $203.10M | $209.80M | $224.22M | $227.45M | $236.95M | $244.85M | $246.81M | $256.04M | $259.46M | $267.21M | $276.92M | 14.2% | -14.0% |
| Mainland China [Member] | $185.66M | $192.93M | $195.55M | $199.96M | $210.46M | $221.94M | $235.24M | $250.31M | $267.52M | $291.17M | $298.08M | $300.50M | 13.5% | -11.8% |
| Manufacturing [Member] | $181.39M | $195.42M | $205.79M | $211.22M | $215.35M | $206.42M | $201.43M | $203.91M | $201.85M | $195.93M | $181.40M | $160.59M | 13.2% | -15.8% |
| Japan [Member] | $164.93M | $171.34M | $174.36M | $179.37M | $182.05M | $180.09M | $181.56M | $185.01M | $191.19M | $199.46M | $207.83M | $210.74M | 12.0% | -9.4% |
| Europe & Africa [Member] | $143.34M | $148.35M | $150.15M | $150.95M | $151.53M | $154.91M | $164.16M | $169.46M | $180.93M | $187.18M | $192.35M | $199.80M | 10.4% | -5.4% |
| Hong Kong/Taiwan [Member] | $114.94M | $116.39M | $117.38M | $120.32M | $122.27M | $128.59M | $130.61M | $139.27M | $146.25M | $149.51M | $153.59M | $152.17M | 8.4% | -6.0% |
| South Korea [Member] | $114.58M | $123.03M | $130.22M | $135.21M | $145.21M | $155.26M | $163.71M | $178.66M | $197.17M | $206.74M | $236.10M | $247.75M | 8.3% | -21.1% |
| Rhyz Other [Member] | $16.31M | $18.61M | $17.79M | $46.95M | $64.35M | $75.88M | $85.19M | $64.71M | $54.14M | $43.50M | $35.21M | $23.24M | 1.2% | -74.7% |
| Nu Skin [Member] | – | – | – | – | – | – | – | – | – | – | – | $1.82B | – | – |
| Rhyz Investments [Member] | – | – | – | – | – | – | – | – | – | – | – | $183.83M | – | – |
| Rhyz [Member] | – | – | – | – | – | – | – | $268.62M | $255.99M | $239.43M | $216.61M | – | – | – |
| Nu Skin [Member] | – | – | – | – | – | – | – | $1.51B | $1.59B | $1.67B | $1.75B | – | – | – |
| Other [Member] | – | – | – | – | – | – | – | – | – | – | – | $1.73M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $50.07M | $55.74M | $60.49M | $65.45M | $67.93M | $68.49M | $67.72M | $65.45M | $66.20M | $77.67M | $78.94M | $90.70M | -26.3% |
| Japan [Member] | $47.46M | $48.48M | $48.97M | $50.64M | $50.90M | $50.65M | $50.80M | $51.24M | $52.37M | $53.17M | $54.08M | $52.27M | -6.8% |
| Mainland China [Member] | $41.71M | $44.83M | $45.56M | $44.76M | $45.47M | $44.39M | $46.09M | $46.97M | $54.92M | $60.90M | $62.26M | $65.68M | -8.3% |
| Southeast Asia/Pacific [Member] | $39.37M | $43.93M | $46.78M | $50.66M | $47.81M | $46.30M | $45.23M | $42.47M | $45.67M | $46.36M | $47.74M | $51.87M | -17.7% |
| Hong Kong/Taiwan [Member] | $35.67M | $36.13M | $37.17M | $37.74M | $36.93M | $37.01M | $34.69M | $37.46M | $38.38M | $40.12M | $40.58M | $36.38M | -3.4% |
| South Korea [Member] | $31.40M | $33.99M | $37.46M | $40.91M | $46.07M | $49.32M | $50.75M | $53.48M | $58.63M | $62.70M | $74.09M | $77.71M | -31.8% |
| Europe & Africa [Member] | $20.39M | $21.72M | $22.63M | $23.55M | $22.91M | $22.40M | $21.01M | $17.32M | $18.69M | $18.23M | $18.59M | $21.57M | -11.0% |
| Manufacturing [Member] | $1.68M | $5.95M | $7.81M | $5.27M | $3.22M | $1.27M | $1.46M | $8.90M | $13.20M | $15.66M | $12.32M | $5.02M | -47.9% |
| Rhyz Other [Member] | -$36.23M | -$35.92M | -$30.59M | -$35.27M | -$36.91M | -$42.25M | -$45.81M | -$23.58M | -$26.63M | -$24.55M | -$20.56M | -$13.43M | -1.8% |
| Nu Skin [Member] | – | – | – | – | – | – | – | – | – | – | – | $433.83M | – |
| Rhyz Investments [Member] | – | – | – | – | – | – | – | – | – | – | – | -$8.41M | – |
| Rhyz [Member] | – | – | – | – | – | – | – | -$14.68M | -$13.43M | -$8.89M | -$8.24M | – | – |
| Nu Skin [Member] | – | – | – | – | – | – | – | $314.40M | $334.85M | $359.14M | $376.29M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Nu Skin Enterprises's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.